Recent Content Related to Synthetic Biology
Montreal - As hundreds of delegates gathered for the Sixth Annual Conference on Industrial Biotechnology and Bioprocessing at Palais des congrès in Old Montreal, a group of NGOs held an early morning press conference across the street.
Montreal. Several groups including Greenpeace, ETC Group and Biofuelwatch are warning that the biotech lobby will mount a major green-washing public relations exercise during the Sixth Annual Conference on Industrial Biotechnology and Bioprocessing that will be held at the Palais de congrès (19-22 July 2009).
ETC Group released a 48-page report, "Who Owns Nature?" on corporate concentration in commercial food, farming, health and the strategic push to commodify the planet's remaining natural resources.
In a world where market research is becoming increasingly proprietary and pricey, ETC Group's report names names, discloses market share and provides top 10 industry rankings up and down the corporate food chain. Not all the corporations identified in ETC Group's new report are household names, but collectively they control a staggering share of the commercial products found on industrial farms, in our refrigerators and medicine cabinets.
In this 100th issue of the ETC Communiqué we update Oligopoly, Inc. – our ongoing series tracking corporate concentration in the life industry. We also analyze the past three decades of agribusiness efforts to monopolize the 24% of living nature that has been commodified, and expose a new strategy to capture the remaining three-quarters that has, until now, remained beyond the market economy.
Peak oil, skyrocketing fuel costs and climate crisis are driving corporate enthusiasm for a “biological engineering revolution” that some predict will dramatically transform industrial production of food, energy, materials, medicine and all of nature. Advocates of converging technologies promise a greener, cleaner post-petroleum future where the production of economically important compounds depends not on fossil fuels – but on biological manufacturing platforms fueled by plant sugars. It may sound sweet and clean, but the so-called “sugar economy” will also be the catalyst for a corporate grab on all plant matter – and destruction of biodiversity on a massive scale.
Synthetic biologists, a brave new breed of science entrepreneurs who engineer life-forms from scratch, will hold their largest-ever global gathering in Hong Kong, October 10-12 2008, known as "Synthetic Biology 4.0." Although most people have never heard of synthetic biology, it's moving full speed ahead fueled by giant agribusiness, energy and chemical corporations with little debate about who will control the technology, how it will be regulated (or not) and despite grave concerns surrounding the safety and security risks of designer organisms. Corporate investors/partners include BP, Chevron, Shell, Virgin Fuels, DuPont, Microsoft, Cargill and Archer Daniels Midland.
Today (21. May 2008) the world learned which corporations, governments, institutions and individuals earned a spot in biopiracy’s hall of shame when the Coalition Against Biopiracy (CAB) announced the winners of the 5th Captain Hook Awards at a lunch-time ceremony during the Ninth Conference of the Parties (COP9) to the Convention on Biological Diversity (CBD) in Bonn, Germany.
ETC Group renewed its call for a moratorium on the release and commercialization of synthetic organisms, asserting that societal debate on the oversight of synthetic biology is urgently overdue. The renewed call came as J. Craig Venter’s research team announced that it has constructed a bacterial-length synthetic genome in the lab using mail-order synthetic DNA sequences. They’ve named the synthetic genome, Mycoplasma genitalium JCVI-1.0, and it’s similar to its counterpart in nature, a genital bacterium with the smallest known genome of any free living organism. The announcement is not breaking news because the work had been previously reported, but the details were published today in Science.
In the name of moving “beyond petroleum,” Big Oil, Gene Giants, governments, start-ups and others are forming partnerships that will extend corporate control over more resources in every part of the globe – while keeping the root causes of climate change intact. With grudging recognition that first-generation agrofuels are neither economical nor ecological, investors turn to other life-based technologies, including synthetic biology, for the next alternative fuel fix.
A report on policy options for governance of synthetic biology is a disappointing effort that fails to address wider societal concerns about the rapid deployment of a powerful and controversial new technology. Synthetic biology aims to commercialize new biological parts, devices and living organisms that are constructed from synthetic DNA - including dangerous pathogens. Synthetic biologists are attempting to harness cells as tiny factories for industrial production of chemicals, including pharmaceuticals and fuels. ETC Group describes the synthetic biology approach as "extreme genetic engineering."
Scientists and industrialists in the controversial new field of synthetic biology (building life-forms from scratch) are meeting in Zurich, Switzerland this week amidst claims that the world’s first entirely human-made organism may be only weeks away from creation. Swiss and international civil society groups are calling for swift action to control this technology but the scientists themselves are advancing pre-emptive proposals to evade regulation. As scientists meet in Zurich, the UK’s Royal Society and the Swiss government announce plans to investigate synthetic biology.
Synthetische Biologie beinhaltet die künstliche – oder eben synthetische – Herstellung von Genen, Lebewesen oder Teilen davon. Es ist ein neues Feld extremer Gentechnik.
Vom 24. bis 26. Juni 2007 fand an der ETH Zürich der dritte weltweite Kongress zur Synthetischen Biologie statt. Schweizerische und internationale Organisationen fordern die Regierungen zu schnellem Handeln auf, um diese neue und potentiell gefährliche Technologie zu regulieren und zu kontrollieren.
Ten years after Dolly the cloned sheep made her stunning debut, the J. Craig Venter Institute is applying for a patent on a new biological bombshell - the world's first-ever human-made species. The novel bacterium is made entirely with synthetic DNA in the laboratory.
Synthia, the (theoretical) human-made synthetic microbe – still barely a twinkle in J. Craig Venter’s eye – may be in search of a surrogate micro-mom sometime very soon. According to a research report released today in Science magazine, Synthia (the subject of a patent application discovered by ETC Group a few weeks ago -see “Goodbye Dolly -- Hello Synthia!”) may have overcome her last hurdle. The report, authored by Craig Venter and his colleagues at Synthetic Genomics Inc., claims to have inserted a foreign bacterial genome into the cell of another bacterial species. Nobel laureate Hamilton Smith who is one of Venter’s co-authors in the research article told a meeting of synthetic biologists in Zürich on Monday that this represents a significant step en route to building a whole new life form. As the article itself concludes, “…we have discovered a form of bacterial DNA transfer that permits … recipient cells to be platforms for the production of new species using modified natural genomes or manmade genomes…”
A new report by the ETC Group concludes that the social, environmental and bio-weapons threats of synthetic biology surpass the possible dangers and abuses of biotech. The full text of the 70-page report, Extreme Genetic Engineering: An Introduction to Synthetic Biology, is available for downloading free-of-charge on the ETC Group website.
"Genetic engineering is passé," said Pat Mooney, Executive Director of ETC Group. "Today, scientists aren't just mapping genomes and manipulating genes, they're building life from scratch - and they're doing it in the absence of societal debate and regulatory oversight," said Mooney.
Issue: Medical applications of nano-scale technologies have the potential to revolutionize healthcare by delivering powerful tools for diagnosing and treating disease at the molecular level. But the current zeal for nano-enabled
medicines could divert scarce medical R&D funds away from essential health services and direct resources away from non-medical aspects of community health and wellbeing. Although nanomedicine is being touted as a solution to pressing health needs in the global South, it is being driven from the North and is designed primarily for wealthy markets. Using nano-scale technologies, the pharmaceutical industry’s ultimate goal is to make every person a patient and every patient a paying customer by “medicating” social ills with human performance enhancement (HyPE) drugs and devices. Nanoenabled HyPEs could usher in an era of two-tiered humans – Homo sapiens and Homo sapiens 2.0.
Synthetic biology (the attempt to create artificial living organisms) should be self-regulated say scientists at Berkeley assembly. Civil Society organizations say "No!"
"If biologists are indeed on the threshold of synthesizing new life forms, the scope for abuse or inadvertent disaster could be huge." Nature, October 2004
Scientists working at the interface of engineering and biology - in the new field of "synthetic biology" - worry that public distrust of biotechnology could impede their research or draw attention to regulatory chasms. Synthetic biologists are trying to design and construct artificial living systems to perform specific tasks, such as producing pharmaceutical compounds or energy. In October 2004, the journal Nature warned, "if biologists are indeed on the threshold of synthesizing new life forms, the scope for abuse or inadvertent disaster could be huge." An editorial in that same issue suggested that there may be a need for an "Asilomar"-type conference on synthetic biology. In light of these concerns, scientists gathering at "Synthetic Biology 2.0" (May 20-22, 2006) at the University of California-Berkeley hope to make "significant progress" toward a "code of ethics and standards." Their actions are intended to project the message that the synthetic biologists are being pro-active and capable of governing themselves as a "community." In their view, self-governance is the best way forward to safely reap the benefits (both societal and financial) of synthetic biology. Civil Society organizations disagree.